Please login to the form below

viruses

This page shows the latest viruses news and features for those working in and with pharma, biotech and healthcare.

respiratory viruses based on the studies we assessed.’.

NICE sees ‘promise’ in four UTI tests that could help in fight against AMR

AMR develops when bacteria, viruses, fungi and parasites change and adapt to antibiotics over time, making them more resistant to drug treatments.
Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

There are no FDA approved vaccines for EBV, one of the most common human viruses.
WHO announces recommended 2023-24 flu vaccines for northern hemisphere

Review the antigenic and genetic characteristics of other recent subtype or variant influenza and the need to develop new candidate vaccine viruses for pandemic preparedness purposes. ... Seasonal influenza is an acute respiratory infection caused by
FDA authorises first at-home COVID-19 and flu test for emergency use

The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) to the first at-home over-the-counter diagnostic test to detect both influenza and COVID-19 viruses. ... viruses. In a statement, the FDA also outlined that all
GSK and Vir Biotech amend COVID-19 research partnership

This was expanded in 2021 to include the research and development of new therapies for influenza and other respiratory viruses. ... GSK. As well as its COVID-19 programmes, Vir’s development pipeline consists of candidates targeting hepatitis B and

More from news
Approximately 4 fully matching, plus 136 partially matching documents found.

World Antimicrobial Awareness Week 2022

AMR develops when bacteria, viruses, fungi and parasites change and adapt to antibiotics over time, making them more resistant to drug treatments.
Creating the urgency and drive needed to tackle antimicrobial resistance

Why antimicrobial resistance is a problem. When bacteria, viruses, fungi and parasites stop responding to medicines, there is a higher risk that diseases will spread.
Keeping up with the developing regulatory requirements for gene and cell therapies

At the same time, any adventitious viruses that could infect the producer cells must also be removed from the final product. ... viruses. At the same time, cell and gene therapies that utilise AAVs and lentiviruses could face difficulty employing these
The search for effective drug treatments for COVID-19

to find an effective drug treatment for patients and the journey of remdesivir that began a decade ago as part of Gilead’s emerging viruses programme. ... We have an emerging viruses programme that is dedicated to developing a large library of
A snapshot of… Enterprise Therapeutics

The mucus can then no longer be moved, so harmful bacteria and viruses are no longer removed, leading to severe infections and inflammation.

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Turnstone Biologics bolsters leadership team

Oncolytic viruses and cancer vaccines have the potential to benefits a wide range of patients living with cancer, and the company’s proprietary viral platform technology is at the forefront of

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Why you should feel optimistic about the future of healthcare

CytImmune Sciences recently completed a Phase I trial using gold nanoparticles to target drug delivery to tumours; BlueWillow Biologics has developed nanotech that fights viruses and bacteria.
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development

Therefore, scientists and public health authorities were already carrying out surveillance in preparation, ready to start research into a vaccine for any concerning viruses that might emerge.
5 Reasons To Add Character Animation To Your Next Campaign.

personality. Whether it's the tone of voice, nationality of your characters or even personified villains such as bacteria or viruses, you're only limited by your imagination.
Brain tumour awareness month: giving research a more humane face

viruses. While this barrier is crucial for survival, it presents a challenge for researchers: they need some substances to be able to get through, such as drugs to treat brain tumours.
Attacking COVID-19 from All Angles

Michael Taylor, CEO &Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating but also

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Early Access Program - Regulatory Affairs (EAP-RA): Highly competitive salary

Associate Director - Global Healthcare Consulting: £100,000 - £115,000 yearly

Add my company

Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...

The speed of science and the pace of comms: Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness: Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story: Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......

Email:
Password: